^

Health

Halazolin

, medical expert
Last reviewed: 23.04.2024
Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Galazolin refers to symptomatic preparations for topical treatment of a common cold of various etiologies in therapeutic, pediatric and otolaryngological practice. This nasal agent has many analogues, including Grippostad Reno, Otrivin, Vonos, Doctor Tayss Nazolin, Influrin, Xylen, Xyloben, Rinazal, Rhinorhom, Rhinostop, Snoop, Suprima-NOZ, Tysin, Pharmazoline and others.

Indications Halazolin

Galazolin is recommended to use to relieve the stuffiness of the nose and improve new breathing in acute rhinitis caused by viral and bacterial infections, as well as allergic rhinitis, chronic rhinitis, nasopharyngitis. Indications for the use of galazolin in otolaryngology are: inflammation of the mucous membranes of the paranasal sinuses ( sinusitis ), allergic sinusopathies, sinusitis, vasomotor rhinitis, in which this drug facilitates the passage of secretions.

In addition, to remove swelling of the mucous nasopharynx Galazoline can be used in complex therapy of inflammation of the middle ear (otitis).

Release form

Galazolin is available in two dosage forms: in the form of nasal gel (in tubes of 10 grams) and solution (in 10 ml bottles) - for application in the form of a drop.

Pharmacodynamics

The mechanism of local symptomatic effects of the drug Galazolin is based on the vasoconstrictive effect of its active substance - xylometazoline hydrochloride.

This substance refers to anticongestants (decongestants) and alpha-adrenergic stimulants. Getting on the mucous membranes of the nose or nasopharynx, xylometazoline hydrochloride stimulates postsynaptic adrenoreceptors (alpha-adrenergic receptors). In response to irritation, a typical alpha-adrenergic effect arises - narrowing of the vessels. The narrowing of the lumens of the blood vessels of the nose and paranasal sinuses, in turn, leads to a rapid decrease in the edema of the nasal passages and a reduction in the volume of mucus secretion. As a result, nasal breathing is restored.

Pharmacokinetics

After the administration of drops or gel, galazoline therapeutic effect begins to be felt at least after 3-5 minutes and can last up to 8-10 hours. However, prolonged use of this drug can lead to a rapid decrease in the therapeutic effect.

Both drops and gel are applied topically (intranasally), so they are almost not absorbed in the blood plasma.

Dosing and administration

0.05% drop. Halozolin is prescribed for children over three years old - 1-2 drops per nostril no more than twice a day. Adults and children after six years should drip 2-3 drops in each nostril 2-3 times a day. Maximum duration of application is 14 days

Galazolin in the form of a gel is used in this dosage: children 3-6 years, one injection into each nostril - 1-2 times a day; children over 6 years and adults - 1-2 injections into each nasal passage 2-3 times during the day.

Use Halazolin during pregnancy

Use of galazoline during pregnancy is not recommended. If there is an extreme need, the prescribing should be prescribed by the attending physician - with the exact observance of the maximum permissible dose.

Contraindications

Among the contraindications to the use of galazolin are such diseases as

Ozona (atrophic rhinitis), arterial hypertension, diagnosed atherosclerosis in severe form, diabetes mellitus, hyperthyroidism (hyperthyroidism) and glaucoma (closed-type).

Side effects Halazolin

The use of any form of galazoline (and its analogs) can cause such side effects as burning in the nose, reddening of the mucosa and reflex response of adrenoreceptors in the form of sneezing.

It should be borne in mind that the continued use of galazoline in chronic nasal congestion can lead to dryness of the mucosa and a disorder of its sensitivity with a temporary loss of smell. It is possible that the mucosal secretions from the nasal cavity, increased heart rate, increased blood pressure, the appearance of headaches and insomnia.

Also, with prolonged intake of galazoline, the ability to drive vehicles and mechanisms can be reduced.

trusted-source[1]

Overdose

Possible overdose of Halazolin is determined by the following symptoms: headache, tachycardia, increased blood pressure, nausea, insomnia and a sense of anxiety.

Interactions with other drugs

The use of galazolin is incompatible with tricyclic antidepressants (anaphranil, melipramine, etc.), as well as sedatives of the group of monoamine oxidase inhibitors. This combination is fraught with a significant increase in blood pressure.

trusted-source[2], [3]

Storage conditions

Storage conditions: Galazolin: protected from light and inaccessible to children, optimal temperature regime - + 15-25 ° C.

trusted-source[4],

Shelf life

Shelf life: drops - 4 years, gel - 3 years from the date of production.

trusted-source

Attention!

To simplify the perception of information, this instruction for use of the drug "Halazolin" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.

Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.

Translation Disclaimer: For the convenience of users of the iLive portal this article has been translated into the current language, but has not yet been verified by a native speaker who has the necessary qualifications for this. In this regard, we warn you that the translation of this article may be incorrect, may contain lexical, syntactic and grammatical errors.

You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.